In recent years, due to the influence of policies such as bidding price reduction and medical insurance control fees, many pharmaceutical manufacturing companies have experienced a series of mergers and acquisitions, and the epitaxial growth has begun to enter a period of growth. Therefore, expanding the original business from the pharmaceutical industry to the medical service field has undoubtedly become one of the ways to try. After all, the policy dividend of social medical treatment continues.

However, just recently, drug companies such as Zuoli Pharmaceuticals and Yishun Pharmaceuticals began to gradually divest the medical service business. Does the “escape” indicate that the “medical industry extends to medical services” does not work?

On December 19th, Yishun Pharmaceutical announced that it intends to transfer 53% equity of Huainan Chaoyang Hospital Management Co., Ltd. through Shenzhen Joint Property Rights Transaction, and the transfer price is not less than 660 million yuan ( Including the number), the final transaction price is determined by the public listing result or the open auction result. After the completion of the transfer, Yiyi Pharmaceutical will no longer hold the equity of Huainan Chaoyang Hospital Management Co., Ltd.

In fact, as early as December 13, 2018, Song Shihe, a shareholder of Huainan Chaoyang Hospital Management Co., Ltd., issued an equity purchase offer to Yishun Pharmaceutical Co., Ltd. to acquire Huainan held by Yishun Pharmaceutical Co., Ltd. at a price of 660 million yuan. 53% equity of Chaoyang Hospital Management Co., Ltd.

If it is because the hospital management company can not achieve profit in a short period of time, it will not be too late for Yishou Pharmaceutical to make a “public listing transfer”. After all, it can be inquired from Yishun Pharmaceutical Announcement, Huainan Chaoyang Hospital Management The company has been in a profitable state for the past two years.

So, why does Yiyi Pharmaceutical transfer a hospital management company that can make long-term profits?

It is not difficult to find that since the investment in the medical service sector in 2015, Yishun Pharmaceutical has started to deploy through the three major actions of “holding private hospitals”, “building a tumor treatment center with hospitals” and “building a tumor doctor group”.

It is also the core advantage of Yizhong Pharmaceutical's cancer treatment drugs, and Yiyi Pharmaceutical actively arranges the field of tumor services. At present, Yishun Pharmaceutical has deployed five operating hospitals with 2,230 open beds and one hospital under construction. In addition, Yiyi Pharmaceutical has invested in 25 cancer treatment center projects and established 7 oncologist groups.

In the investment layout of the Yiyi Pharmaceutical Medical Services segment, the general hospital provides comprehensive medical services for patients; the doctors group provides key oncologist resources and technical support to host the oncology department of Yiyi Pharmaceutical Tumor Chain Hospital or Public Hospital. Implement technical output and management, set up a day clinic to carry out medical services, and carry out VIP management of cancer patients, provide follow-up guidance for medical treatment, provide high-quality MDT services for cancer patients, and use cancer equipment for project cooperation. The hospital provides equipment operation management, and the service fee is the main business model.

Yi'ou Health Review Yishen Pharmaceutical's revenue from the two major modules of the pharmaceutical industry and medical services from 2015 to the present, it is found that before 2017, the revenue of these two modules will continue to grow. Until the first half of 2018, the pharmaceutical industry's revenue began to decline. In this regard, in the first half of 2018, Yishun Pharmaceutical pointed out that the core Chinese patent medicine products were affected by the related policies such as bidding price reduction and medical insurance control fees, and the revenues decreased in different degrees year-on-year. The growth of chemical drug revenues was strong, and some hedged the decline in revenue of the pharmaceutical industry sector.

In the first half of 2018, among the operating income of Yiyi Pharmaceutical, the pharmaceutical industry sector accounted for 77.69%, and the medical service sector accounted for 22.31%. Compared with 100% of the pharmaceutical industry revenue in 2014, the income of the medical services sector in Yizhong Pharmaceutical's overall revenue is undoubtedly rising year by year.

Returning to the move of Yishun Pharmaceutical to publicly sign Huainan Chaoyang Hospital Management Co., Ltd., Yiou Health believes that the relatively reasonable explanation is the income caused by short-term transfer, which can fill the pharmaceutical industry sector camp in the first half of the year to a certain extent. The decline in revenue led to a blank revenue and hedged the downward trend.

Fresh Red Garlic

Introduction:

The bulb of garlic,an allium plant in the lily family.with the pungent flavor and spicy taste.spherical shape with a diameter of 3-6.5cm. The surface is covered with white and papery-skin.

The top is slightly pointed, with residual scape in the middle,many fibrous root marks at the base. After peeling off the skin, a single head or 6 to 16 petal-shaped small bulbs, inserted around the base of the remaining flower stems. The bulbous valve is slightly ovoid, with a membranous outer skin, slightly pointed at the apex, and an arcuate bulge on one side.

In order to ensure the maximum freshness and nutrients.

We adhere to the traditional natural drying method without any human intervention.

Our fresh red garlic contains thiamine, riboflavin, nicotinic acid, allicin, citral, selenium and germanium.etc

Therefore help to improve immunity,anti-aging,lower blood sugar and pressure,improve indigestion etc.

what'more,it`s the easy way to improve flavor,add unique aroma for your food.

Specification

Brand:Changrong

Variety:Liliaceous Vegetables

Color:Purple red

Fresh Red Garlic,Chesnok Red Garlic,Red Chinese Garlic,Natural Fresh Red Garlic

shandong changrong international trade co.,ltd. , https://www.changronggarliccn.com